Literature DB >> 323640

Gram-negative bacillary pneumonia in the compromised host.

M Valdivieso, B Gil-extremera, J Zornoza, V Rodriquez, G P Bodey.   

Abstract

The clinical and radiological characteristics of 217 consecutive episodes of gram-negative bacillary pneumonia occurring in 189 adult cancer patients between November 1968 and December 1974 were analyzed. The majority of patients had acute leukemia (54%). Fever larger than or equal to 101 degrees F was the single most common symptom and sign of the presence of infection (90%). Next in frequency were crepitant rales (65%), cough (41%), dyspnea (19%) and chest pain (18%). Radiographic evidence of pneumonia was found in 83% of cases and it consisted mainly of alveolar infiltrates involving both lung fields and predominantly the bases. Up to one-third of the patients had normal chestx-ray examinations at the onset of infection, though they subsequently became abnormal in 42% of them. The majority of patients (81%) whose initial chest x-rays did not reveal the presence of pneumonia were neutropenic (less than 1000 circumlating neutrophils/mm3). Klebsiella sp. and Pseudomonas sp. were the most common infecting organisms. The overall cure rate was 61%; 70% for Klebsiella sp. infections and 64% for Pseudomonas sp. infections. Pulmonary abscesses occurred in 14% of the cases. Cures were related to the antibiotic sensitivity of the infecting organisms and to the number of circulating neutrophils during the period of infection. Best results were obtained with the administration of gentamicin, the newer aminoglycoside antibiotic sisomicin, tobramycin and amikacin, or the combination of gentamicin with carbenicillin or with cephalosporins. Early and vigorous therapy of gram-negative bacillary pneumonia with appropriate antibiotics has improved the prognosis of this infection at our institution.

Entities:  

Mesh:

Year:  1977        PMID: 323640     DOI: 10.1097/00005792-197705000-00005

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  12 in total

1.  Emerging pathogens in nosocomial pneumonia.

Authors:  S L Berk; A Verghese
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

Review 2.  Nosocomial pneumonia in patients in intensive care units.

Authors:  S D Podnos; G B Toews; A K Pierce
Journal:  West J Med       Date:  1985-11

3.  Pneumatocele formation in a patient with Proteus mirabilis pneumonia.

Authors:  J Lysy; A Werczberger; M Globus; I Chowers
Journal:  Postgrad Med J       Date:  1985-03       Impact factor: 2.401

4.  Bacteriostatic and bactericidal activities of beta-lactam antibiotics enhanced by the addition of low concentrations of gentamicin.

Authors:  G Masuda; K Nakamura; T Yajima; K Saku
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

5.  Pneumonia during the treatment of acute leukaemia.

Authors: 
Journal:  Br Med J       Date:  1980-11-08

6.  Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.

Authors:  I A Bakker-Woudenberg; J C van den Berg; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

7.  Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients.

Authors:  L Jadeja; R Bolivar; V Fainstein; M Keating; K McCredie; M Hay; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

Review 8.  Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

9.  Requirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilli.

Authors:  P Leist-Welsh; A B Bjornson
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

10.  Serum-induced lysis of Pseudomonas aeruginosa.

Authors:  T Meshulam; H Verbrugh; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1982-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.